Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study
Table 3
The U-MD, LO-V and RO-V after leuprorelin acetate injection.
Group
U-MD (cm)
∆U-MD (cm)
LO-V (mL)
∆LO-V (mL)
RO-V (mL)
∆RO-V (mL)
Baseline
6-mon
P value
Baseline
6-mon
P value
Baseline
6-mon
P value
LA3-mon
2.48 ± 0.48
2.45 ± 0.35
0.192
0.18 ± 0.36
2.44 ± 0.95
1.53 ± 1.04
0.048
0.73 ± 1.08
2.50 ± 0.93
1.68 ± 0.74
0.048
0.79 ± 1.17
LA1-mon
2.69 ± 0.58
2.53 ± 0.54
0.077
0.23 ± 0.59
2.98 ± 1.28
1.78 ± 1.12
0.024
1.19 ± 1.28
3.07 ± 1.45
2.01 ± 0.89
0.031
0.90 ± 1.26
t
1.494
0.544
−0.269
1.651
0.691
0.863
1.669
1.232
0.207
value
0.141
0.590
0.790
0.106
0.494
0.400
0.101
0.226
0.838
Data are presented as mean ± standard deviation. Abbreviations: U-MD, maximum diameter of uterus; LO-V, volume of left ovary; RO-V, volume of right ovary.
